Cargando...
Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD. More clinical trials on suPAR is in the future research agenda.
Guardado en:
| Publicado en: | Ann Card Anaesth |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4900352/ https://ncbi.nlm.nih.gov/pubmed/27052059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-9784.179588 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|